NanoCap ICS:ASX They run a UK Medical Billing Portal
NanoCap ICS:ASX They run a UK Medical Billing Portal. Estimated FY15 P/E 10.5, NPAT growth circa 25% based on the low end of guidance, pays a small unfranked dividend and leverage to a falling AUD/GBP FX rate. Mkt Cap $10mil. Its profitable, growing organically, dividend paying, with good free cash-flow these are statements you don't normally make about stocks down this end of the market.
I focus on ASX listed microcap and nanocap stocks which is anything from $10mil to $300mil market cap and everything in between. This truly is the under-researched part of the ASX. My hope is to bring you interesting microcap stocks and news.